Immunogenicity of influenza vaccine in elderly people: a systematic review and meta-analysis of randomized controlled trials, and its association with real-world effectiveness
Background: Older people (≥60 years old) are particularly vulnerable to influenza virus infection, and vaccine is effective in reducing the disease burden in this population. However, it remains obscure whether their antibody response is lower than those of younger adults (18-60 years old). Thus, th...
Saved in:
Main Authors: | Ziyan Meng (Author), Jiayou Zhang (Author), Jinrong Shi (Author), Wei Zhao (Author), Xiaoyuan Huang (Author), Li Cheng (Author), Xiaoming Yang (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2020-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Safety and immunogenicity of a quadrivalent, inactivated, split-virion influenza vaccine (IIV4-W) in healthy people aged 3-60 years: a phase III randomized clinical noninferiority trial
by: Xiaoyuan Huang, et al.
Published: (2022) -
Immunogenicity of H5N1 influenza vaccines in elderly adults: a systematic review and meta-analysis
by: Ke Zhang, et al.
Published: (2021) -
Safety and immunogenicity of a quadrivalent influenza vaccine in adults aged 60 years or above: a phase III randomized controlled clinical study
by: Renfeng Fan, et al.
Published: (2022) -
Factors influencing the immunogenicity of influenza vaccines
by: Simin Wen, et al.
Published: (2021) -
Immunogenicity of high-dose trivalent inactivated influenza vaccine: a systematic review and meta-analysis
by: Sandrine I. Samson, et al.
Published: (2019)